跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Approvals
/
CIMA-AEMPS
/
IMCIVREE 10 MG/ML SOLUCION INYECTABLE
Approved
STANDARD
IMCIVREE 10 MG/ML SOLUCION INYECTABLE
Rhythm Pharmaceuticals Netherlands B.V.
🇪🇸 Spanish Agency of Medicines and Medical Devices
Approval Date
May 19, 2022
Approval ID
7deb97f4b7552929
Company
Rhythm Pharmaceuticals Netherlands B.V.
Type
Standard
Approval Details
Approval Id
7deb97f4b7552929
Drug Cima Aemps Name
IMCIVREE 10 MG/ML SOLUCION INYECTABLE
Register Number
1211564001
Holder Company Name
Rhythm Pharmaceuticals Netherlands B.V.
Marketing Company Name
Rhythm Pharmaceuticals Spain, S.L.U.
Holder Company Detail Path
/organization/rhythm-pharmaceuticals-netherlands-bv
Authorization Date
2022-05-19
Dosage Form
SOLUCIÓN INYECTABLE
Dose
10 mg/ml
Route Of Administration
VÍA SUBCUTÁNEA
Prescription Type
Uso Hospitalario
Commercialized
Yes
Company Name
Rhythm Pharmaceuticals Netherlands B.V.
Company Detail Path
/organization/rhythm-pharmaceuticals-netherlands-bv
Company Information
Pharmaceutical Company Name
Rhythm Pharmaceuticals Netherlands BV
Country Name
Netherlands
Active Ingredients
SETMELANOTIDA
10 mg
Approved
Quick Info
Agency
CIMA-AEMPS
Country
🇪🇸
Approval Date
May 19, 2022
Approval ID
7deb97f4b7552929
Type
Standard
Back to CIMA-AEMPS Approvals
IMCIVREE 10 MG/ML SOLUCION INYECTABLE - CIMA-AEMPS Drug Approval Details